Subscribe To
ITRM / Iterum Therapeutics to Present Data at IDWeek 2023
ITRM News
By GlobeNewsWire
October 12, 2023
Iterum Therapeutics to Present Data at IDWeek 2023
DUBLIN, Ireland and CHICAGO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical c more_horizontal
By GlobeNewsWire
August 4, 2023
Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023
DUBLIN, Ireland and CHICAGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical c more_horizontal
By GlobeNewsWire
June 12, 2023
Iterum Therapeutics to Present Data at ASM Microbe 2023
DUBLIN, Ireland and CHICAGO, June 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical c more_horizontal
By GlobeNewsWire
March 9, 2023
Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023
DUBLIN, Ireland and CHICAGO, March 09, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical more_horizontal
By InvestorPlace
July 11, 2022
Why Is Iterum Therapeutics (ITRM) Stock Up 73% Today?
Iterum Therapeutics (ITRM) stock is taking off on Monday as investors react to news of a clinical trial agreement with the FDA. The post Why Is Iterum more_horizontal
By Seeking Alpha
March 28, 2022
Iterum Therapeutics plc (ITRM) CEO Corey Fishman on Q4 2021 Results - Earnings Call Transcript
Iterum Therapeutics plc (ITRM) CEO Corey Fishman on Q4 2021 Results - Earnings Call Transcript more_horizontal